Location: Home
  • search
  • go
  • Relate News
  • 3/21/2019Merck To Collaborate with GenScript to Accelerate Cell and Gene Therap...
  • 3/20/2019GSK-Pfizer Consumer Healthcare JV Start to Take Shape in China
  • 3/20/2019UCB to Focus on CNS, Disposing Niferex to Nuance Biotech
  • 3/20/2019China Needs 30 Times Its Outsourcing Capacity to Meet Biologics Demand...
  • 3/20/2019MorphoSys and I-Mab Announce Initiation of Pivotal Phase 2 Study of Mu...
  • 3/20/2019China Said to be Back-paddling on Pharma IP Stances as High-level US-C...
  • 3/19/2019CanSinoBio to Launch $161M Hong Kong IPO
  • 3/19/2019MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Ge...
  • 3/19/2019ImmunoBiology and CNBG Enter Licensing Pact to Co-Develop Vaccine for ...
  • 3/19/2019Korean Pharma Il-yang and Hanmi Report Robust Sales Growth in China
  • 3/19/2019Takeda to Invest CNY 110M into Expanding Its Chinese Manufacturing Fac...
  • 3/19/2019Merck KGaA Aims to Double China Sales by 2025
  • 3/17/2019Xynomic Pharma Gains Phase III Trial Approval for Novel RCC Drug Combo...
  • 3/17/20195 Key Elements of Chinese Biopharma's "Cambrian Explosion"
  • 3/15/2019NHSA Releases 2018 Healthcare Security Sector Development Statistical ...
  • 3/15/2019Upcoming Event: 4th Asean Pharma Packaging Conference
  • 3/15/2019Upcoming Event: Precision Medicine Congress
  • 3/15/2019Recent Executive Moves
  • 3/15/2019Upcoming Event: 3rd Publishers Summit
  • 3/15/2019Upcoming Event: 3rd edition of the Shanghai eHealth Workshop
  • 3/15/2019Pharma China Annual Forum 2019 (April 9, Shanghai)
  • 3/15/2019China Approves New Law against Forced Tech Transfers
  • 3/15/2019Alibaba Partners with 12 Pharma Firms to Retrieve Expired Medicine
  • 3/15/2019Astellas Launches Teijin's Gout Medicine Feburic in China
  • 3/14/2019CDE Solicits Public Comments on Clinical Trial Guideline for NASH Drug...
  • 3/14/2019China Faces A Daunting Healthcare Bill from Heart Disease
  • 3/14/2019Chinese Experts Warn of Rising Kidney Disease in the Country
  • 3/14/2019CStone Received IND Approval in China for HDAC6 Inhibitor CS3003
  • 3/13/2019A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says
  • 3/13/2019CASI Pharma Announces Exclusive Distribution Partner for Melphalan in ...
  • Page:290/775 Total number of articles:23243: [First][<<] [288] [289] [290] [291] [292] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group